The Centers for Disease Control and Prevention (CDC) has awarded more than $15 million to 41 investigators through the Antibiotic Resistance Solutions Initiative for research to detect antibiotic resistance, shape treatment and prevention recommendations, and prevent the spread of antibiotic-resistant infections.
Awardees include five association members:
- Henry Ford Health System, in Detroit, for a study that aims to improve antibiotic selection and reduce excess length of antibiotic therapy through pharmacist-led prescription reviews at the time of discharge;
- The Ohio State University, in Columbus, Ohio, for three studies that examine antimicrobial use on crops, salmonella production in dairy calves, and antibiotic stewardship education for calf producers;
- University of California Irvine, in Orange, Calif., for a study that aims to reduce post-discharge invasive Staphylococcus aureus infections;
- University of Chicago, in Chicago, for a project to design a genetic sequencing panel to identify antibiotic-resistant genes from stool samples; and
- University of Virginia, in Charlottesville, Va., for two projects: one to examine antibiotic breakpoints for drug-resistant Shigella at a hospital in Bangladesh; and one to explore prevention methods for Carbapenemase-producing Gammaproteobacteria in health care facilities’ plumbing systems.
Solicitation for 2019 awards will begin in March. CDC will host a webinar on the application process for 2019 innovation funding on Nov. 30 from 10 am to noon ET.
Essential hospitals also are participating in CDC’s Antimicrobial Challenge, a yearlong effort to reduce antimicrobial and antibiotic resistance.
Contact Senior Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.
Author